INSIGHTEC AT RSNA 2014
HAIFA, Israel, November 25, 2014 - INSIGHTEC, world leader in MR-guided Focused Ultrasound (MRgFUS) will be on site at the RSNA 100th annual meeting to present its MR-guided Focused Ultrasound solution for ablation of uterine fibroids and alleviation of pain caused by bone metastases.
INSIGHTEC's non-invasive therapeutic technology is at the forefront of re-purposing the MRI suite from a purely diagnostic platform into a tool for delivering advanced care to patients in an ambulatory setting.
INSIGHTEC representatives will be on-site at the RSNA to discuss the recent announcement made by the Health Care Service Corporation (HCSC) to include coverage of INSIGHTEC's solution for pain palliation of bone metastases, opening the door to many patients who suffer from metastatic bone disease and have not responded to, or have rejected, radiation therapy.
INSIGHTEC has also finalized the enrolment of the FDA pivotal study for its neurosurgery application on Essential Tremor. Current clinical investigations for the technology also include treatments of prostate cancer, liver cancer, pancreas cancer, and breast cancer.
In addition to showcasing its solutions, INSIGHTEC will also proudly present its new corporate identity, designed to accentuate the company's values around innovation, precision, clinical effectiveness, positive outcomes and accessibility while giving the company a more contemporary, future-facing and updated look and feel.
We invite you to visit INSIGHTEC at the GE booth 3539, talk to our representatives, see a demonstration and learn more about our unique non-invasive technological solution that is transforming patient care around the world.